Stock listing

NASDAQ:HUMA Humacyte, Inc. Stock

Home listing (NASDAQ) of Humacyte, Inc.

Follow Humacyte, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:HUMA

$0.445 USD -0.055 (-10.9%)

Close on Nov 20, 2026

Past year -60.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.444 – $0.520 USDNov 20, 2026
Volume
5.77M sharesNov 20, 2026
Market cap
$123.7M USDAt the close on Nov 20, 2026 · price × 277.8M shares outstanding
52-week range
$0.337 – $1.525 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.80M USDMedian day 4.63M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Humacyte, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:HUMA · Home$0.445 USD-0.055 (-10.9%)5,771,034$0.513$0.520$0.444$0.500Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HUMA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.445-0.055-10.9%$0.513$0.520$0.4445,771,034
$0.500-0.001-0.2%$0.505$0.529$0.4853,906,847
$0.501-0.039-7.3%$0.540$0.575$0.5014,343,121
$0.540-0.018-3.2%$0.556$0.578$0.5253,043,482
$0.558-0.037-6.2%$0.600$0.610$0.5354,625,129
$0.595+0.004+0.6%$0.587$0.630$0.5635,229,709
$0.592+0.002+0.3%$0.587$0.626$0.5546,778,329
$0.590+0.135+29.6%$0.500$0.597$0.49215,666,482
$0.455+0.007+1.6%$0.450$0.493$0.4505,663,214
$0.448+0.052+13.1%$0.410$0.449$0.4005,152,000
$0.396-0.054-12.0%$0.440$0.449$0.3876,011,900
$0.450+0.009+2.0%$0.460$0.475$0.4252,641,900
$0.441+0.043+10.8%$0.405$0.445$0.3913,203,400
$0.398-0.013-3.2%$0.424$0.432$0.3855,214,400
$0.411-0.059-12.6%$0.460$0.460$0.4005,119,900
$0.4700.0000.0%$0.473$0.510$0.4603,704,500
$0.470+0.024+5.4%$0.450$0.479$0.4322,657,500
$0.446+0.045+11.2%$0.414$0.464$0.3943,715,700
$0.401-0.034-7.8%$0.460$0.462$0.3913,975,300
$0.435+0.022+5.3%$0.420$0.440$0.3992,607,700
$0.413+0.002+0.5%$0.410$0.420$0.4002,252,100
$0.411+0.005+1.2%$0.410$0.420$0.3924,174,100
$0.406+0.005+1.2%$0.392$0.416$0.3904,884,200
$0.401-0.028-6.5%$0.428$0.439$0.3914,691,500
$0.429-0.011-2.5%$0.450$0.460$0.4205,962,100
$0.440+0.086+24.3%$0.366$0.446$0.35120,787,000
$0.354-0.005-1.4%$0.363$0.379$0.3375,431,100
$0.359-0.031-7.9%$0.390$0.391$0.35612,348,200
$0.390-0.015-3.7%$0.400$0.413$0.38716,347,100
$0.405-0.042-9.4%$0.440$0.449$0.3918,597,900
$0.447-0.025-5.3%$0.475$0.480$0.4375,485,200
$0.472-0.006-1.3%$0.479$0.480$0.4603,908,900
$0.478-0.022-4.4%$0.501$0.510$0.4724,281,100
$0.500-0.022-4.2%$0.520$0.522$0.4856,449,400
$0.522+0.019+3.8%$0.506$0.534$0.5035,395,400
$0.503-0.015-2.9%$0.520$0.528$0.5012,995,300
$0.518-0.015-2.8%$0.540$0.548$0.5105,739,900
$0.533-0.014-2.6%$0.549$0.550$0.5313,610,700
$0.547-0.010-1.8%$0.550$0.569$0.5324,959,200
$0.557-0.012-2.1%$0.560$0.571$0.5502,618,600
$0.569+0.003+0.5%$0.560$0.573$0.5432,833,900
$0.566-0.017-2.9%$0.588$0.588$0.5563,431,600
$0.583-0.007-1.2%$0.588$0.608$0.5813,468,900
$0.590+0.004+0.7%$0.600$0.610$0.5753,405,200
$0.586+0.011+1.9%$0.570$0.608$0.5706,987,700
$0.575+0.005+0.9%$0.595$0.598$0.5652,900,300
$0.570+0.018+3.3%$0.558$0.596$0.5504,955,300
$0.552-0.009-1.6%$0.560$0.570$0.5403,209,700
$0.561-0.007-1.2%$0.550$0.575$0.5503,160,900
$0.568+0.001+0.2%$0.576$0.588$0.5592,255,200
$0.567-0.012-2.1%$0.580$0.580$0.5602,661,200
$0.579-0.016-2.7%$0.591$0.600$0.5752,917,400
$0.595-0.010-1.7%$0.610$0.610$0.5802,402,000
$0.605+0.009+1.5%$0.591$0.610$0.5832,961,900
$0.596-0.001-0.2%$0.608$0.610$0.5843,016,700
$0.597+0.027+4.7%$0.571$0.611$0.5705,175,500
$0.570-0.031-5.2%$0.598$0.601$0.57016,536,100
$0.601-0.049-7.5%$0.650$0.650$0.58413,537,600
$0.650-0.043-6.2%$0.690$0.695$0.6404,916,000
$0.693+0.011+1.6%$0.700$0.708$0.6872,961,800
$0.682-0.019-2.7%$0.710$0.712$0.6705,677,000
$0.701+0.039+5.9%$0.663$0.730$0.6605,920,952
$0.662+0.020+3.1%$0.675$0.694$0.6423,758,871
$0.642-0.039-5.7%$0.674$0.700$0.6359,360,200
$0.681-0.054-7.3%$0.707$0.715$0.6636,648,200
Ticker
NASDAQ:HUMA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Humacyte, Inc. news

Humacyte, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
45 in the last 12 months · 141 in all · newest Nov 19, 2026 · oldest 2021
Calls
20 calls with a replay · 20 with a transcript · latest Nov 10, 2026
Decks
8 decks · latest Jun 10, 2026

Where Humacyte, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HUMA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:HUMABOATSUnited StatesUSD

Valuation

EV/sales 40.1× against a median of 7.8×: 5th lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$96.01M USD
P/E
Loss
EV/sales
40.1×
EV/EBITDA
Negative EBITDA
Price/book
6.8×
Gross margin
−549.8%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
2.0×
Beta vs S&P 500
2.56

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Humacyte, Inc. · NASDAQ:HUMAUS$123.7MUS$96.01Mn/a40.1×n/a6.8×n/a2.0×2.56
Yoda Pharmaceuticals Inc. · TPEX:7829US$127.1MUS$94.39Mn/an/an/a3.9×n/a0.0×n/a
UnicoCell Biomed Co., Ltd. · TWSE:6794US$126.3MUS$106.5Mn/a117×n/a5.1×−381.5%0.1×n/a
MacroGenics, Inc. · NASDAQ:MGNXUS$125.3M−US$127.6Mn/a−0.9×n/a5.0×−34.6%1.4×0.83
PolyPid Ltd. · NASDAQ:PYPDUS$124.3MUS$119.3Mn/an/an/a23.1×n/a0.3×0.93
Compass Therapeutics, Inc. · NASDAQ:CMPXUS$123.9M−US$29.89Mn/an/an/a0.9×n/a0.1×1.22
Biomm SA · BMFBOVESPA:BIOM3US$123.5MUS$137.5M18.4×2.1×12.3×2.2×10.3%0.3×n/a
Invivyd, Inc. · NASDAQ:IVVDUS$122.0MUS$3.86Mn/a0.1×n/a0.8×−214.8%0.1×2.06
Satellos Bioscience Inc · TSX:MSCLUS$121.9MUS$69.24Mn/an/an/a2.5×n/a0.0×0.49
Alar Pharmaceuticals Inc · TPEX:6785US$121.0MUS$51.67Mn/a568×n/a1.7×n/a0.0×n/a
CANbridge Pharmaceuticals Inc. · HKEX:1228US$120.4MUS$111.5Mn/a13.4×n/an/a−146.4%n/an/a
Median of the othersUS$123.7MUS$81.81M18.4×7.8×12.3×2.5×−146.4%0.1×0.93

Forecasts

3 strong buy · 1 buy · 2 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
1.64 USD · Analysts' mean
EPS, year to Dec 2026
-0.40 · 4 analysts
Revenue, year to Dec 2026
3.86M · 4 analysts

Team and board

Officers

OfficerRole
Laura E. NiklasonPresident, Chief Executive Officer, Member of the Board
Dale SanderChief Corporate Development Officer, Chief Financial Officer & Treasurer
Matt PanningVice President, Manufacturing
Matt UdelhofenVice President, MSAT
Heather ConnellyChief Quality and Regulatory Officer
Jim MercadanteChief Commercial Officer
Lisa MolyneuxChief Strategy Officer
Sabrina OsborneChief People Officer
Shamik ParikhChief Medical Officer
Todd RasmussenChief Surgical Officer

Board

DirectorRole
Kathleen SebeliusChair of the Board
Brady W. DouganMember of the Board
C. Bruce GreenMember of the Board, Member of Audit Committee, Member of Commercial Committee
Diane SeimetzMember of the Board, Member of Commercial Committee
Emery N. BrownMember of the Board, Member of Nominating and Governance Committee
John P. BamforthMember of the Board, Chair of Commercial Committee
Keith Anthony JonesMember of the Board, Chair of Compensation Committee
Laura E. NiklasonPresident, Chief Executive Officer, Member of the Board
Max WallaceMember of the Board, Chair of Nominating and Governance Committee, Member of Compensation Committee
Michael T. ConstantinoMember of the Board, Chair of Audit Committee
Susan Windham-BannisterMember of the Board, Member of Audit Committee, Member of Commercial Committee

Events

Calls

CallWhenStatus
Humacyte (NASDAQ:HUMA) Q3 2026 Earnings CallTue, Nov 10, 2026 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q2 2026 Earnings CallWed, Aug 12, 2026 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q1 2026 Earnings CallWed, May 13, 2026 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q4 2025 Earnings CallFri, Mar 27, 2026 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q3 2025 Earnings CallWed, Nov 12, 2025 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q2 2025 Earnings CallMon, Aug 11, 2025 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q1 2025 Earnings CallTue, May 13, 2025 · 8:30 AM ETReplay
Humacyte (NASDAQ:HUMA) Q4 2024 Earnings CallFri, Mar 28, 2025 · 8:30 AM ETReplay
Humacyte (NASDAQ:HUMA) Q3 2024 Earnings CallFri, Nov 08, 2024 · 8:30 AM ETReplay
Humacyte (NASDAQ:HUMA) Q2 2024 Earnings CallTue, Aug 13, 2024 · 8:30 AM ETReplay
All 20 calls
CallWhenStatus
Humacyte (NASDAQ:HUMA) Q1 2024 Earnings CallFri, May 10, 2024 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q4 2023 Earnings CallFri, Mar 22, 2024 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q3 2023 Earnings CallThu, Nov 09, 2023 · 4:30 PM ETReplay
Humacyte (NASDAQ:HUMA) Q2 2023 Earnings CallMon, Aug 14, 2023 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q1 2023 Earnings CallFri, May 12, 2023 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q4 2022 Earnings CallFri, Mar 24, 2023 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q3 2022 Earnings CallThu, Nov 10, 2022 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q2 2022 Earnings CallFri, Aug 12, 2022 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q1 2022 Earnings CallFri, May 13, 2022 · 8:00 AM ETReplay
Humacyte (NASDAQ:HUMA) Q4 2021 Earnings CallTue, Mar 29, 2022 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 10, 2026 · Before open+29.6%
Q2 2026Aug 12, 2026 · Before open−6.3%
Q1 2026May 13, 2026 · Before open+24.2%
Q4 2025Mar 26, 2026−17.9%
Q3 2025Nov 12, 2025 · Before open−2.3%
Q2 2025Aug 11, 2025 · Before open−29.6%
Q1 2025May 13, 2025 · Before open+31.1%
Q4 2024Mar 20, 2025 · Before open−3.9%
Q3 2024Nov 8, 2024 · Before open+9.9%
Q2 2024Aug 13, 2024 · Before open+0.5%
All 20 quarters
QuarterResultsShare move
Q1 2024May 10, 2024 · Before open+4.0%
Q4 2023Mar 22, 2024 · Before open−8.1%
Q3 2023Nov 9, 2023 · After close+6.3%
Q2 2023Aug 14, 2023 · Before open+23.6%
Q1 2023May 12, 2023 · Before open−6.5%
Q4 2022Mar 24, 2023 · Before open−5.8%
Q3 2022Nov 10, 2022 · Before open+3.8%
Q2 2022Aug 12, 2022 · Before open+5.0%
Q1 2022May 13, 2022 · Before open+6.5%
Q4 2021Mar 29, 2022 · Before open+5.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (June 2026)Investor deck55 slidesJun 10, 2026
Corporate Update (March 2026)Corporate update55 slidesMar 19, 2026
Investor Presentation (March 2025)Investor deck52 slidesMar 25, 2025
Investor Presentation (February 2024)Investor deck41 slidesFeb 29, 2024
Investor Presentation (January 2022)Investor deck37 slidesJan 10, 2022
Alpha Healthcare Acquisition — SPAC Merger (June 2021)SPAC merger122 slidesJun 7, 2021
SPAC Merger (February 2021)SPAC merger38 slidesFeb 17, 2021
Investor PresentationInvestor deck57 slides

Open Decks

Financings

RaiseDate
Registered direct offering of common stock and warrants
Announced: about US$60M · US$2.11 a share · 1 warrant at US$2.11 · D. Boral Capital LLC
Dealers: D. Boral Capital LLC (lead)
Oct 7, 2025
Public offering of common stock
Announced: US$50M · US$2 a share · TD Cowen +4
Dealers: TD Cowen (co-lead), Barclays (co-lead), BTIG (co-lead), H.C. Wainwright & Co., The Benchmark Company
Use of proceeds: Commercialization of SYMVESS in vascular trauma, pipeline product development, working capital and general corporate purposes
Mar 26, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as Alpha Healthcare Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Sep 17, 2020.

Price
US$10.00 a unit
Units offered
10,000,000 units
Offering size
US$100 million
Underwriters' option
Up to 1,500,000 more units
Listing
AHACU on the Nasdaq Capital Market
Underwriters
Oppenheimer & Co., Northland Capital Markets · In the order on the cover
Units delivered
On or about Sep 22, 2020

Steps

StepWhen
Filed publiclyAug 4, 2020
Amended twiceNewest Sep 14, 2020
Shares registered with an exchangeSep 17, 2020
Declared effective by the SECSep 17, 2020
Final prospectus, with the priceSep 18, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Sep 18, 2020

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue2.04M001.56M1.26M1.49M6.19M
Cost of revenue9.70M076.5M8.26M61.3M54.1M75.6M
Gross profit-15.0M-7.19M-76.5M-6.69M-60.1M-52.6M-69.4M
Research and development69.3M88.6M76.5M63.3M61.3M54.1M75.6M
Selling, general and administrative31.2M25.8M23.4M22.9M21.0M11.9M16.3M
Operating income-108.1M-114.4M-100.0M-84.6M-81.2M-64.6M-85.7M
Depreciation and amortization5.33M5.10M5.66M6.15M6.18M6.29M6.75M
EBITDA-102.8M-109.3M-94.4M-78.4M-75.0M-58.3M-78.9M
Interest expense11.3M9.28M6.60M6.20M4.35M2.20M2.30M
Income before tax-40.8M-148.7M-110.8M-12.0M-26.5M-66.5M-85.4M
Income tax000000
Net income-40.8M-148.7M-110.8M-12.0M-26.5M-66.5M-85.4M
Earnings per share, basic-0.26-1.26-1.07-0.12-0.66-11.54-0.83
Earnings per share, diluted-0.26-1.26-1.07-0.12-0.66-11.54

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents50.5M44.9M80.4M149.8M217.5M39.9M93.7M
Short-term investments02.11M8.00M0
Receivables441.0K0031.0K176.0K113.0K601.0K
Inventory13.6M0-31.0K111
Current assets67.8M47.9M83.3M154.2M229.3M41.4M95.0M
Property, plant and equipment18.5M23.1M26.8M30.0M35.0M41.0M73.7M
Total assets116.4M137.9M128.2M204.3M286.5M106.7M168.7M
Accounts payable5.40M4.49M6.49M1.59M2.09M2.27M3.27M
Current liabilities18.4M20.0M18.4M19.6M11.1M11.2M10.8M
Long-term debt35.4M38.6M20.3M27.4M822.0K
Total debt35.4M057.5M50.1M30.0M28.9M28.7M
Total liabilities113.3M190.5M114.7M87.4M164.4M36.0M36.5M
Shareholders' equity3.11M-52.7M13.5M116.9M122.2M-350.3M132.2M
Shares outstanding193.0M130.0M103.7M103.2M103.0M5.82M103.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-105.0M-98.1M-73.3M-71.1M-81.2M-55.6M-71.8M
Capital spending-884.0K-1.57M-2.28M-1.05M-220.0K-318.0K-8.13M
Free cash flow-105.9M-99.7M-75.6M-72.2M-81.4M-55.9M-79.9M
Cash from investing-884.0K-1.57M-173.0K4.84M-8.22M-268.0K-8.13M
Cash from financing61.5M114.2M4.51M-1.45M267.0M2.05M-74.0K
Dividends paid00
Share buybacks708.0K535.0K243.0M
Change in cash-44.4M14.5M-69.0M-67.7M177.6M-53.8M-80.0M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 10, 2026ResultsSEC
4 · Change in ownershipOct 7, 2026Insider tradeSEC
4 · Change in ownershipOct 7, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 28, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 28, 2026Insider tradeSEC
8-K · Current reportSep 28, 2026Management or board changeSEC
4 · Change in ownershipSep 15, 2026Insider tradeSEC
25-NSEAug 25, 2026Other filingsSEC
4 · Change in ownershipAug 21, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 19, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 18, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
8-K · Current reportAug 12, 2026ResultsSEC
8-K · Current reportJul 31, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 28, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 13, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJun 22, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 15, 2026Big-stake noticeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
8-K · Current reportJun 11, 2026Material contractSEC
424B5 · ProspectusJun 11, 2026Offer documentSEC
424B5 · ProspectusJun 10, 2026Offer documentSEC
8-K · Current reportJun 10, 2026Current reportSEC
8-K · Current reportJun 9, 2026Meeting outcomeSEC
8-K · Current reportJun 5, 2026Current reportSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
144 · Notice of proposed saleMay 18, 2026Other filingsSEC
144 · Notice of proposed saleMay 18, 2026Other filingsSEC
S-8 · Registration statement for employee plansMay 14, 2026Offer documentSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
8-K · Current reportMay 8, 2026Current reportSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 27, 2026Big-stake noticeSEC
8-K · Current reportApr 24, 2026Material contractSEC
PRE 14A · Preliminary proxy statementApr 17, 2026Meeting noticeSEC
10-K · Annual reportMar 27, 2026Annual reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 24, 2026Big-stake noticeSEC
8-K · Current reportMar 19, 2026Material contractSEC
424B3 · ProspectusMar 19, 2026Offer documentSEC
8-K · Current reportMar 19, 2026ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 9, 2026Big-stake noticeSEC
8-K · Current reportDec 16, 2025Material contractSEC
424B5 · ProspectusDec 16, 2025Offer documentSEC
8-K · Current reportDec 15, 2025Material contractSEC
8-K · Current reportDec 15, 2025Current reportSEC
424B3 · ProspectusDec 15, 2025Offer documentSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
8-K · Current reportNov 26, 2025Current reportSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportNov 12, 2025ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 16, 2025Big-stake noticeSEC
8-K · Current reportOct 7, 2025Material contractSEC
424B3 · ProspectusOct 7, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 23, 2025Other filingsSEC
424B3 · ProspectusSep 22, 2025Offer documentSEC
CORRESP · Letter to the SECSep 18, 2025Other filingsSEC
8-K · Current reportSep 17, 2025Material contractSEC
UPLOAD · Letter from the SECSep 17, 2025Other filingsSEC
S-3 · Registration statementSep 12, 2025Offer documentSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
144 · Notice of proposed saleAug 20, 2025Other filingsSEC
144 · Notice of proposed saleAug 19, 2025Other filingsSEC
144 · Notice of proposed saleAug 18, 2025Other filingsSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
8-K · Current reportAug 11, 2025ResultsSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
8-K · Current reportJun 11, 2025Meeting outcomeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 22, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
8-K · Current reportMay 13, 2025ResultsSEC
DEFA14A · Additional proxy materialApr 29, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2025Meeting noticeSEC
8-K · Current reportApr 17, 2025Current reportSEC
PRE 14A · Preliminary proxy statementApr 17, 2025Meeting noticeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
4 · Change in ownershipApr 14, 2025Insider tradeSEC
4 · Change in ownershipApr 14, 2025Insider tradeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMar 31, 2025Offer documentSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
8-K · Current reportMar 28, 2025ResultsSEC
8-K · Current reportMar 27, 2025Current reportSEC
8-K · Current reportMar 26, 2025Material contractSEC
424B5 · ProspectusMar 26, 2025Offer documentSEC
424B3 · ProspectusMar 25, 2025Offer documentSEC
8-K · Current reportMar 25, 2025Current reportSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
8-K · Current reportDec 20, 2024Current reportSEC
4 · Change in ownershipDec 4, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedNov 20, 2024Big-stake noticeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
144 · Notice of proposed saleNov 20, 2024Other filingsSEC
144 · Notice of proposed saleNov 19, 2024Other filingsSEC
144 · Notice of proposed saleNov 18, 2024Other filingsSEC
SC 13D/A · Big-stake notice, amendedNov 18, 2024Big-stake noticeSEC
8-K · Current reportNov 14, 2024Material contractSEC
424B3 · ProspectusNov 14, 2024Offer documentSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
SC 13G · Big-stake noticeNov 8, 2024Big-stake noticeSEC
8-K · Current reportNov 8, 2024ResultsSEC
8-K · Current reportOct 28, 2024Current reportSEC
SC 13G · Big-stake noticeOct 24, 2024Big-stake noticeSEC
8-K · Current reportOct 7, 2024Material contractSEC
424B3 · ProspectusOct 4, 2024Offer documentSEC
424B3 · ProspectusSep 25, 2024Offer documentSEC
8-K · Current reportSep 24, 2024Material contractSEC
4 · Change in ownershipSep 16, 2024Insider tradeSEC
4 · Change in ownershipSep 11, 2024Insider tradeSEC
4 · Change in ownershipSep 11, 2024Insider tradeSEC
4 · Change in ownershipSep 11, 2024Insider tradeSEC
144 · Notice of proposed saleSep 10, 2024Other filingsSEC
144 · Notice of proposed saleSep 10, 2024Other filingsSEC
144 · Notice of proposed saleSep 9, 2024Other filingsSEC
4 · Change in ownershipSep 3, 2024Insider tradeSEC
4 · Change in ownershipSep 3, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedSep 3, 2024Big-stake noticeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
144 · Notice of proposed saleAug 29, 2024Other filingsSEC
144 · Notice of proposed saleAug 28, 2024Other filingsSEC
144 · Notice of proposed saleAug 27, 2024Other filingsSEC
144 · Notice of proposed saleAug 27, 2024Other filingsSEC
4 · Change in ownershipAug 15, 2024Insider tradeSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
UPLOAD · Letter from the SECAug 13, 2024Other filingsSEC
8-K · Current reportAug 13, 2024ResultsSEC
CORRESP · Letter to the SECAug 6, 2024Other filingsSEC
8-K · Current reportJul 31, 2024Current reportSEC
UPLOAD · Letter from the SECJul 23, 2024Other filingsSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
3 · Initial statement of ownershipJun 17, 2024Insider tradeSEC
3 · Initial statement of ownershipJun 17, 2024Insider tradeSEC
8-K · Current reportJun 13, 2024Management or board changeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
144 · Notice of proposed saleJun 12, 2024Other filingsSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJun 4, 2024Big-stake noticeSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
144 · Notice of proposed saleJun 4, 2024Other filingsSEC
4 · Change in ownershipJun 3, 2024Insider tradeSEC

This page holds 200 of 506 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Humacyte, Inc.’s releases · as of Nov 10, 2026

Common shares
277,798,105
Fully diluted
277,798,105

Fully diluted

LineSharesAs of
Common shares277,798,105Nov 10, 2026

Share count over time

CountShares
Nov 10, 2026277,798,105

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard13.4M4.8%US$6.97MSep 30, 2026
ANTIPODES PARTNERS Ltd8.26M3.0%US$4.28MSep 30, 2026
BlackRock4.57M1.6%US$2.36MSep 30, 2026
Great Point Partners LLC3.75M1.3%US$1.94MSep 30, 2026
UBS3.01M1.1%US$1.56MSep 30, 2026
Marshall Wace, LLP3M1.1%US$1.56MSep 30, 2026
Geode Capital2.68M0.96%US$1.39MSep 30, 2026
Citadel1.73M0.62%US$897KSep 30, 2026
Susquehanna1.67M0.60%US$865KSep 30, 2026
Schwab1.38M0.50%US$712KSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Private Advisor Group, LLC948K0.34%US$491KSep 30, 2026
LPL Financial LLC938K0.34%US$486KSep 30, 2026
Wealth Effects LLC920K0.33%US$476KSep 30, 2026
State Street901K0.32%US$466KSep 30, 2026
Lion Point Capital, LP650K0.23%US$337KSep 30, 2026
Northern Trust587K0.21%US$304KSep 30, 2026
Woodline Partners LP501K0.18%US$259KSep 30, 2026
Invesco449K0.16%US$232KSep 30, 2026
Gsa Capital Partners LLP335K0.12%US$173KSep 30, 2026
Morgan Stanley260K0.09%US$135KSep 30, 2026
LJI Wealth Management, LLC253K0.09%US$131KSep 30, 2026
Goldman Sachs243K0.09%US$126KSep 30, 2026
United Asset Strategies, Inc.210K0.08%US$109KSep 30, 2026
Hudson Bay Capital Management LP195K0.07%US$101KSep 30, 2026
Catalyst Funds Management Pty Ltd162K0.06%US$83,929Sep 30, 2026
Bridgeway Capital Management, LLC157K0.06%US$81,475Sep 30, 2026
Empowered Funds, LLC157K0.06%US$81,475Sep 30, 2026
Creative Planning149K0.05%US$77,204Sep 30, 2026
Group One Trading LLC137K0.05%US$70,715Sep 30, 2026
Bolton Securities Corporation120K0.04%US$62,124Sep 30, 2026
AQR Capital Management LLC114K0.04%US$59,045Sep 30, 2026
LaSalle St. Investment Advisors, LLC112K0.04%US$57,762Sep 30, 2026
Renaissance Technologies110K0.04%US$57,087Sep 30, 2026
Cetera Investment Advisers109K0.04%US$56,526Sep 30, 2026
Miramontes Capital, LLC109K0.04%US$56,271Sep 30, 2026
Endowment Wealth Management, Inc.105K0.04%US$505KSep 30, 2026
Two Sigma92,7830.03%US$48,034Sep 30, 2026
Bank of America88,5070.03%US$45,758Sep 30, 2026
Schonfeld Strategic Advisors LLC86,5800.03%US$44,822Sep 30, 2026
Kovack Advisors, Inc.82,6000.03%US$42,763Sep 30, 2026
Barclays76,0010.03%US$39,346Sep 30, 2026
Advisors Capital Management, LLC73,6570.03%US$38,132Sep 30, 2026
Concurrent Investment Advisors, LLC71,4790.03%US$37,005Sep 30, 2026
Engineers Gate Manager LP61,9070.02%US$32,049Sep 30, 2026
BNP Paribas57,6340.02%US$29,837Sep 30, 2026
Integrity Alliance, LLC.57,3000.02%US$29,664Sep 30, 2026
Beacon Pointe Advisors, LLC56,0000.02%US$28,992Sep 30, 2026
BNY55,8440.02%US$28,910Sep 30, 2026
Osaic Holdings, Inc.53,6720.02%US$28,318Sep 30, 2026
China Universal Asset Management Co., Ltd.50,6870.02%US$27,001Sep 30, 2026

This page holds 50 of 126 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund7.72M2.8%US$6.02MJun 30, 2026
Vanguard Extended Market Index Fund2.12M0.76%US$1.66MJun 30, 2026
iShares Biotechnology ETF1.44M0.52%US$1.12MJun 30, 2026
Fidelity Extended Market Index Fund839K0.30%US$1.09MMay 31, 2026
Vanguard Russell 2000 Index Fund836K0.30%US$1.09MMay 31, 2026
Schwab U.S. Small-Cap ETF729K0.26%US$947KMay 31, 2026
Modern Capital Tactical Income Fund590K0.21%US$460KJun 30, 2026
Vanguard Health Care Index Fund475K0.17%US$617KMay 31, 2026
Schwab Total Stock Market Index Fund415K0.15%US$271KJul 31, 2026
Fidelity Total Market Index Fund277K0.10%US$360KMay 31, 2026
All 43 holders
HolderSharesOf the companyValueAs of
Invesco RAFI US 1500 Small-Mid ETF243K0.09%US$159KJul 31, 2026
Fidelity Series Total Market Index Fund234K0.08%US$304KMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF167K0.06%US$130KJun 30, 2026
Ultra-Small Company Market Fund160K0.06%US$125KJun 30, 2026
Vanguard Institutional Total Stock Market Index Fund136K0.05%US$106KJun 30, 2026
Vanguard Balanced Index Fund132K0.05%US$103KJun 30, 2026
Fidelity Nasdaq Composite Index Fund102K0.04%US$132KMay 31, 2026
Vanguard Russell 2000 Value Index Fund96,7840.03%US$126KMay 31, 2026
Fidelity ZERO Total Market Index Fund91,9620.03%US$60,088Jul 31, 2026
Small Cap Index Fund70,8220.03%US$92,069May 31, 2026
Schwab U.S. Broad Market ETF68,9700.02%US$89,661May 31, 2026
Fidelity ZERO Extended Market Index Fund68,5760.02%US$44,808Jul 31, 2026
Bridge Builder Small/Mid Cap Value Fund62,7440.02%US$48,965Jun 30, 2026
Goldman Sachs Absolute Return Tracker Fund55,8380.02%US$43,576Jun 30, 2026
Vanguard Russell 2000 Growth Index Fund35,9330.01%US$46,713May 31, 2026
Fidelity Flex Small Cap Index Fund30,7440.01%US$20,088Jul 31, 2026
Victory Extended Market Index Fund23,262<0.01%US$15,199Jul 31, 2026
Siit Extended Market Index Fund14,991<0.01%US$19,488May 31, 2026
VIP Extended Market Index Portfolio11,911<0.01%US$9,295Jun 30, 2026
Invesco Nasdaq Biotechnology ETF10,180<0.01%US$13,234May 31, 2026
Vanguard Russell 3000 Index Fund9,770<0.01%US$12,701May 31, 2026
ProShares Russell 2000 High Income ETF7,628<0.01%US$9,916May 31, 2026
ProShares Ultra Nasdaq Biotechnology7,136<0.01%US$9,277May 31, 2026
ProShares UltraPro Russell20006,034<0.01%US$7,844May 31, 2026
ProShares Ultra Russell20005,965<0.01%US$7,755May 31, 2026
Bridge Builder Small/Mid Cap Growth Fund5,134<0.01%US$4,007Jun 30, 2026
VIP Total Market Index Portfolio4,026<0.01%US$3,142Jun 30, 2026
Total Stock Market Index Trust3,863<0.01%US$3,015Jun 30, 2026
Morgan Stanley Pathway Small-Mid Cap Equity ETF3,350<0.01%US$4,355May 31, 2026
Destinations Small-Mid Cap Equity Fund3,124<0.01%US$4,061May 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND1,149<0.01%US$751Jul 31, 2026
ProShares Hedge Replication ETF151<0.01%US$196May 31, 2026
ProShares Russell 2000 Dynamic Buffer ETF47<0.01%US$61May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Jones Keith Anthony
Director
Buy10,000USD 0.56US$5,600Sep 14, 2026
Jones Keith Anthony
Director
Buy10,000USD 0.69US$6,900Aug 20, 2026
Jones Keith Anthony
Director
Buy30,000USD 0.59US$17,700Aug 17, 2026
Sebelius Kathleen
Director
Buy56,818USD 0.88US$50,000May 19, 2026
Constantino Michael T.
Director
Buy11,000USD 0.89US$9,790May 18, 2026
Sander Dale A.
Officer: CFO and Chief Corp. Dev. Off
Sale45,887USD 0.90US$41,298May 18, 2026
Parikh Shamik J
Officer: Chief Medical Officer
Sale45,887USD 0.90US$41,298May 18, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajiv Shukla
Other companies: Longevity Health Holdings, Inc. (Chairman and CEO, Director · Jul 26, 2021 – Oct 11, 2024 · Past); Constellation Alpha Capital Corp (CEO & Chairman, Director · Jun 19, 2017 – Jun 23, 2017 · Past)
Director · Sep 17, 2020 – Jun 15, 2023 · Past
Patrick A Sturgeon
Other companies: Longevity Health Holdings, Inc. (Director · Jul 26, 2021 – Oct 11, 2024 · Past)
CFO · Sep 17, 2020 – Sep 17, 2020 · Past
Brady W. DouganDirector · Since at least Aug 26, 2021
Bruce A SpringerDirector · Sep 17, 2020 – Sep 17, 2020 · Past
C. Bruce GreenMember of the Board, Member of Audit Committee, Member of Commercial Committee · Since at least Nov 5, 2026
Charles Bruce GreenDirector · Since at least Sep 15, 2022
Dale SanderChief Corporate Development Officer, Chief Financial Officer & Treasurer · Since at least Aug 26, 2021
Diane SeimetzMember of the Board, Member of Commercial Committee · Since at least Nov 5, 2026
Emery N. BrownMember of the Board, Member of Nominating and Governance Committee · Since at least Nov 5, 2026
Gordon M BinderDirector · Aug 26, 2021 – May 15, 2024 · Past
All 31 people
PersonSeat
Heather ConnellyChief Quality and Regulatory Officer · Since at least Nov 4, 2026
Heather Ledbetter PrichardChief Operating Officer · Aug 26, 2021 – Jan 21, 2025 · Past
Jim MercadanteChief Commercial Officer · Since at least Oct 15, 2026
John P. BamforthDirector · Since at least Jun 11, 2024
Kathleen SebeliusDirector · Since at least May 19, 2026
Keith Anthony JonesMember of the Board, Chair of Compensation Committee · Since at least Jun 11, 2024
Laura E. NiklasonPresident, CEO and Director, Director · Since at least Jun 12, 2025
Lisa MolyneuxChief Strategy Officer · Since at least Nov 4, 2026
Matt PanningVice President, Manufacturing · Since at least Nov 4, 2026
Matt UdelhofenVice President, MSAT · Since at least Nov 4, 2026
Max WallaceDirector · Since at least Nov 21, 2023
Michael T. ConstantinoDirector · Since at least Aug 26, 2021
Paul Brian KuznikDirector · Since at least Sep 22, 2026
Rick McElhenySenior Vice President of Business Development · Mar 26, 2026 – Nov 5, 2026 · Past
Sabrina OsborneChief People Officer · Since at least Nov 4, 2026
Shamik ParikhChief Medical Officer · Since at least May 20, 2026
Susan Windham-BannisterMember of the Board, Member of Audit Committee, Member of Commercial Committee · Since at least Nov 5, 2026
Todd PopeDirector · Since at least Jun 12, 2025
Todd RasmussenChief Surgical Officer · Since at least Aug 12, 2026
William Edward TenteChief Regulatory Officer · Aug 26, 2021 – Aug 26, 2021 · Past
Yang CaoChief Regulatory Officer · Sep 19, 2022 – Jan 21, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Humacyte, Inc.